Remedee Labs SA makes non-drug neuromodulation devices, including the Remedee bracelet, to help relieve chronic pain.
Founded in 2016 by David Crouzier and Michael Foerster and headquartered in Saint-Martin, France, Remedee Labs SA develops non-pharmacological devices for chronic pain. Its Remedee bracelet uses millimeter-wave neuromodulation, and its Novi Rem and Fibro Rem products target osteoarthritis and fibromyalgia in France. The company raised EUR 10.050 mn in a Series B round on December 6, 2022, with investors including Banque Hottinguer and Bpifrance. It reported EUR 242,867.40 in revenue for 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in